Nandan Biomatrix, a Hyderabad based Nutraceutical company, is all set to boost its business operations in the current year through significant investment in R&D activities. The company expects to double its turnover to Rs 100 crore from current level of Rs 40 crore.

The company has been involved in R&D pertaining to herbal and medicinal products. Nanadan Biomatrix has integrated capabilities in natural products, which makes it an ideal partner in the pursuit of business goals.

Speaking with Pharmabiz, V Bhaskar Rao, managing director, said, "We are expanding our R&D capacity in the next financial year. Through this expansion we are hoping to achieve turnover of Rs 100 core. Nandan's R&D is very strong with state of the art laboratories with advanced processing and extraction facilities in enhancing therapeutic principles and standardization of extracts of various herbs. Currently nearly 600 people are working in its R&D centre."

The company has recently entered into joint venture agreement with Austrian Bio-fuels Institute, which is pursing advanced research in the production of bio-fuels. "We have around 20 products in our product pipeline and also considering tie-ups with multinational companies. At present we are focusing more on Nutraceutical products, but now we are planning to move in Biofuels segment in a big way", he further added.

The company has tied up with ICRISAT, internationally recognized organization, which is involved in fundamental agriculture research. Nandan has covered the critical components that decide the long-term viability of a business organization. In some specific instances this ability of led to substantial increase in productivity of its partners business.